skip to main content

Prostate Cancer

The PSA: Questions and Answers

Todd Morgan, M.D. of the U-M Multidisciplinary Urologic Oncology Clinic answers questions about prostate cancer biomarkers and explains how they help in prostate cancer treatment.

Quality of life meets cure for prostate cancer treatment

A new paper looks at how MRI and a clear understanding of the functional anatomy around the prostate can allow radiation oncologists to plan a course of treatment for patients with prostate cancer that spares these critical structures.

Researchers find protein that may signal more aggressive prostate cancers

University of Michigan researchers have discovered a biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer.

Researchers develop new potential drug for rare leukemia

Researchers have developed a new drug candidate that shows potential in laboratory studies against a rare type of acute leukemia. And additional studies suggest the same compound could play a role in prostate cancer treatment as well.

Researchers open ‘Pandora’s box’ of potential cancer biomarkers

Researchers at the University of Michigan Rogel Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored. This analysis opens the door to discovery of thousands of potential new cancer biomarkers.